Arrowstreet Capital’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,921,130
| Closed | -$221M | – | 2010 |
|
|
2026
Q1 | $221M | Sell |
2,921,130
-101,949
| -3% | -$7.66M | 0.12% | 160 |
|
|
2025
Q4 | $225M | Buy |
3,023,079
+105,661
| +4% | +$7.72M | 0.13% | 160 |
|
|
2025
Q3 | $197M | Buy |
2,917,418
+149,605
| +5% | +$9.93M | 0.12% | 163 |
|
|
2025
Q2 | $180M | Buy |
2,767,813
+606,782
| +28% | +$36.4M | 0.13% | 156 |
|
|
2025
Q1 | $133M | Buy |
2,161,031
+473,684
| +28% | +$31.4M | 0.11% | 174 |
|
|
2024
Q4 | $122M | Buy |
1,687,347
+361,539
| +27% | +$28.2M | 0.1% | 192 |
|
|
2024
Q3 | $108M | Buy |
1,325,808
+237,843
| +22% | +$19M | 0.09% | 186 |
|
|
2024
Q2 | $80.8M | Buy |
1,087,965
+159,180
| +17% | +$11.9M | 0.07% | 225 |
|
|
2024
Q1 | $72.4M | Sell |
928,785
-428,004
| -32% | -$31.8M | 0.07% | 246 |
|
|
2023
Q4 | $96.9M | Sell |
1,356,789
-553,069
| -29% | -$38.5M | 0.1% | 173 |
|
|
2023
Q3 | $133M | Sell |
1,909,858
-899,599
| -32% | -$68M | 0.16% | 126 |
|
|
2023
Q2 | $227M | Sell |
2,809,457
-1,237,148
| -31% | -$101M | 0.28% | 88 |
|
|
2023
Q1 | $327M | Sell |
4,046,605
-98,134
| -2% | -$7.9M | 0.42% | 62 |
|
|
2022
Q4 | $310M | Buy |
4,144,739
+181,720
| +5% | +$12.9M | 0.43% | 67 |
|
|
2022
Q3 | $256M | Buy |
3,963,019
+515,270
| +15% | +$35.7M | 0.38% | 75 |
|
|
2022
Q2 | $239M | Buy |
3,447,749
+1,551,575
| +82% | +$115M | 0.34% | 76 |
|
|
2022
Q1 | $146M | Buy |
1,896,174
+995,854
| +111% | +$71.6M | 0.18% | 136 |
|
|
2021
Q4 | $68.9M | Sell |
900,320
-20,245
| -2% | -$1.49M | 0.08% | 240 |
|
|
2021
Q3 | $67.9M | Sell |
920,565
-438,366
| -32% | -$32.9M | 0.09% | 253 |
|
|
2021
Q2 | $90.7M | Buy |
1,358,931
+898,691
| +195% | +$60.1M | 0.11% | 200 |
|
|
2021
Q1 | $34.2M | Buy |
460,240
+368,458
| +401% | +$28M | 0.05% | 396 |
|
|
2020
Q4 | $6.68M | Buy |
+91,782
| New | +$6.48M | 0.01% | 1080 |
|
|
2020
Q2 | – | Sell |
-700,440
| Closed | -$24.6M | – | 2366 |
|
|
2020
Q1 | $24.6M | Buy |
700,440
+642,240
| +1,104% | +$30.6M | 0.07% | 254 |
|
|
2019
Q4 | $3.04M | Buy |
+58,200
| New | +$2.9M | 0.01% | 1001 |
|
|
2018
Q4 | – | Sell |
-35,600
| Closed | -$1.46M | – | 1399 |
|
|
2018
Q3 | $1.46M | Buy |
+35,600
| New | +$1.44M | ﹤0.01% | 731 |
|
|
2017
Q2 | – | Sell |
-31,500
| Closed | -$1.34M | – | 1175 |
|
|
2017
Q1 | $1.34M | Buy |
+31,500
| New | +$1.28M | ﹤0.01% | 904 |
|
|
2016
Q3 | – | Sell |
-69,000
| Closed | -$2.39M | – | 1541 |
|
|
2016
Q2 | $2.39M | Sell |
69,000
-401,329
| -85% | -$13.9M | 0.01% | 781 |
|
|
2016
Q1 | $16.2M | Sell |
470,329
-49,035
| -9% | -$1.71M | 0.07% | 276 |
|
|
2015
Q4 | $20.1M | Buy |
+519,364
| New | +$20.2M | 0.09% | 217 |
|
|
2015
Q1 | – | Sell |
-170,574
| Closed | -$4.56M | – | 1092 |
|
|
2014
Q4 | $4.56M | Buy |
+170,574
| New | +$4.4M | 0.03% | 473 |
|
Other funds holding HOLX
Arrowstreet Capital's HOLX Position: Q2 2026 in Review
Arrowstreet Capital sold out of Hologic (HOLX) in Q2 2026, closing a stake of 2,921,130 shares — an estimated $221M sold.
Arrowstreet Capital first reported a position in HOLX in Q4 2014 and held it in 30 quarters. The position peaked at $327M in Q1 2023. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Arrowstreet Capital reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Arrowstreet Capital sold 2,921,130 Hologic shares in Q2 2026, an estimated $221M.
- Arrowstreet Capital first reported a position in Hologic in Q4 2014 and held it in 30 quarters.
- Arrowstreet Capital's Hologic position peaked at $327M in Q1 2023.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.